Chien Chung Chen
Finanzdirektor/CFO bei Vita Genomics, Inc.
Profil
Chien Chung Chen is currently the Chief Financial Officer at Vita Genomics, Inc. Previously, he worked as an Independent Director at Kuangli Bio-Tech Holdings Co. Ltd.
Chen received his undergraduate degree from Soochow University.
Aktive Positionen von Chien Chung Chen
| Unternehmen | Position | Beginn |
|---|---|---|
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Chien Chung Chen
| Unternehmen | Position | Ende |
|---|---|---|
| KUANGLI BIO-TECH HOLDINGS CO., LTD. | Direktor/Vorstandsmitglied | - |
Ausbildung von Chien Chung Chen
| Soochow University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KUANGLI BIO-TECH HOLDINGS CO., LTD. | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
